Total Payments
$19,409
2024 Payments
$2,848
Companies
36
Transactions
602
Medicare Patients
910
Medicare Billing
$269,780
Payment Breakdown by Category
Food & Beverage$14,976 (77.2%)
Consulting$4,000 (20.6%)
Education$433.09 (2.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,976 | 591 | 77.2% |
| Consulting Fee | $4,000 | 1 | 20.6% |
| Education | $433.09 | 10 | 2.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $5,587 | 53 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,855 | 64 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $1,453 | 69 | $0 (2024) |
| ITI, Inc. | $1,325 | 43 | $0 (2023) |
| ABBVIE INC. | $1,217 | 58 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $933.61 | 18 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $761.09 | 39 | $0 (2024) |
| Indivior Inc. | $632.71 | 21 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $620.54 | 26 | $0 (2022) |
| Axsome Therapeutics, Inc. | $587.43 | 16 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,848 | 113 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) ($456.65) |
| 2023 | $3,896 | 158 | ITI, Inc. ($532.32) |
| 2022 | $2,853 | 113 | ITI, Inc. ($637.52) |
| 2021 | $2,084 | 97 | Janssen Pharmaceuticals, Inc ($412.95) |
| 2020 | $1,052 | 48 | Teva Pharmaceuticals USA, Inc. ($178.31) |
| 2019 | $1,966 | 52 | Teva Pharmaceuticals USA, Inc. ($541.37) |
| 2018 | $669.88 | 17 | Alkermes, Inc. ($262.68) |
| 2017 | $4,041 | 4 | Alkermes, Inc. ($4,000) |
All Payment Transactions
602 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $19.75 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/19/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $27.40 | General |
| Category: PSYCHIATRY | ||||||
| 12/18/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: Neuroscience | ||||||
| 12/13/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $21.84 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/11/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $27.85 | General |
| Category: Neuropsychiatry | ||||||
| 12/09/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $28.71 | General |
| Category: CNS | ||||||
| 12/05/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $27.51 | General |
| Category: Neuropsychiatry | ||||||
| 12/04/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $28.61 | General |
| Category: CNS | ||||||
| 11/25/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: PSYCHIATRY | ||||||
| 11/22/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $23.24 | General |
| Category: PSYCHIATRY | ||||||
| 11/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $33.35 | General |
| Category: Neuropsychiatry | ||||||
| 11/08/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $4.24 | General |
| Category: Neuropsychiatry | ||||||
| 11/07/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $29.25 | General |
| Category: CNS | ||||||
| 11/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $117.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $34.91 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/01/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $22.42 | General |
| Category: Psychiatry/Psychology | ||||||
| 10/31/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.02 | General |
| Category: PSYCHIATRY | ||||||
| 10/30/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: Neuropsychiatry | ||||||
| 10/25/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $29.53 | General |
| Category: CNS | ||||||
| 10/23/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | Cash or cash equivalent | $96.63 | General |
| Category: SCHIZOPHRENIA | ||||||
| 10/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.45 | General |
| Category: NEUROSCIENCE | ||||||
| 10/15/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $26.48 | General |
| Category: PSYCHIATRY | ||||||
| 10/09/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $11.92 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 226 | 944 | $165,430 | $85,440 |
| 2022 | 2 | 180 | 774 | $133,925 | $66,300 |
| 2021 | 3 | 200 | 655 | $113,064 | $58,619 |
| 2020 | 6 | 304 | 846 | $125,260 | $59,421 |
Total Patients
910
Total Services
3,219
Medicare Billing
$269,780
Procedure Codes
14
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 167 | 868 | $142,880 | $74,981 | 52.5% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 48 | 48 | $16,800 | $6,419 | 38.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 28 | $5,750 | $4,040 | 70.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 148 | 740 | $122,025 | $61,339 | 50.3% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 32 | 34 | $11,900 | $4,961 | 41.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 147 | 597 | $96,504 | $51,856 | 53.7% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 40 | 41 | $14,350 | $6,041 | 42.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 13 | 17 | $2,210 | $721.50 | 32.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 138 | 490 | $70,815 | $35,085 | 49.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 47 | 215 | $26,875 | $12,786 | 47.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 26 | 27 | $6,750 | $4,432 | 65.7% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 29 | 29 | $9,865 | $3,136 | 31.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 38 | 58 | $7,445 | $2,358 | 31.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 26 | 27 | $3,510 | $1,624 | 46.3% |
About Dr. Jeffrey Klopper, MD
Dr. Jeffrey Klopper, MD is a Psychiatry healthcare provider based in Smyrna, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1033282017.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeffrey Klopper, MD has received a total of $19,409 in payments from pharmaceutical and medical device companies, with $2,848 received in 2024. These payments were reported across 602 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($14,976).
As a Medicare-enrolled provider, Klopper has provided services to 910 Medicare beneficiaries, totaling 3,219 services with total Medicare billing of $269,780. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Smyrna, GA
- Active Since 11/16/2006
- Last Updated 09/08/2010
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1033282017
Products in Payments
- Aristada 441 mg (Drug) $4,263
- CAPLYTA (Drug) $1,782
- VRAYLAR (Drug) $1,217
- ARISTADA (Drug) $1,061
- INVEGA SUSTENNA (Drug) $1,041
- AUSTEDO (Drug) $970.47
- SPRAVATO (Drug) $814.65
- REXULTI (Drug) $782.71
- INGREZZA (Drug) $761.09
- LATUDA (Drug) $620.54
- ABILIFY MAINTENA (Drug) $589.94
- Auvelity (Drug) $587.43
- TRINTELLIX (Drug) $358.73
- QELBREE (Drug) $354.07
- Dayvigo (Drug) $344.37
- PERSERIS (Drug) $329.94
- SUBLOCADE (Drug) $302.77
- FANAPT (Drug) $298.27
- LYBALVI (Drug) $263.02
- NUEDEXTA (Drug) $260.65
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Smyrna
Karl Mihalovits, Md, MD
Psychiatry — Payments: $10,826
Psychiatry $10,826
Dominic Nkwocha, Md, MD
Psychiatry — Payments: $4,824
Psychiatry $4,824
Dr. Gary Weichbrodt, M.d, M.D
Psychiatry — Payments: $3,342
Psychiatry $3,342
Hemachandra Gunawardhana, Md, MD
Psychiatry — Payments: $2,940
Psychiatry $2,940
Dr. Bharatkumar Patel, Md, MD
Psychiatry — Payments: $2,875
Psychiatry $2,875
Ronald Jackson, M.d, M.D
Psychiatry — Payments: $2,687
Psychiatry $2,687